[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 270,121
  • Shares Outstanding, K 94,448
  • Annual Sales, $ 824,500 K
  • Annual Income, $ -365,900 K
  • EBIT $ -64 M
  • EBITDA $ 309 M
  • 60-Month Beta 1.64
  • Price/Sales 0.62
  • Price/Cash Flow 1.43
  • Price/Book 1.50

Options Overview Details

View History
  • Implied Volatility 114.71% (-7.85%)
  • Historical Volatility 191.80%
  • IV Percentile 28%
  • IV Rank 11.58%
  • IV High 586.89% on 02/19/26
  • IV Low 52.89% on 08/12/25
  • Expected Move (DTE 19) 0.31 (10.70%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 2,566
  • Volume Avg (30-Day) 217
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 2,906
  • Open Int (30-Day) 2,262
  • Expected Range 2.55 to 3.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.03
  • Number of Estimates 2
  • High Estimate $0.03
  • Low Estimate $0.02
  • Prior Year $-0.13
  • Growth Rate Est. (year over year) +123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.81 +1.78%
on 07/31/26
6.43 -55.52%
on 07/16/26
-2.85 (-49.91%)
since 06/30/26
3-Month
2.81 +1.78%
on 07/31/26
6.43 -55.52%
on 07/16/26
-1.89 (-39.79%)
since 04/30/26
52-Week
2.81 +1.78%
on 07/31/26
8.59 -66.71%
on 10/16/25
-1.19 (-29.38%)
since 07/30/25

Most Recent Stories

More News
Why Myriad Genetics (MYGN) Shares Are Falling Today

Why Myriad Genetics (MYGN) Shares Are Falling Today

MYGN : 2.86 (-46.74%)
Myriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6%

Myriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6%

MYGN : 2.86 (-46.74%)
Myriad: Q2 Earnings Snapshot

Myriad: Q2 Earnings Snapshot

MYGN : 2.86 (-46.74%)
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

Highl ights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year....

MYGN : 2.86 (-46.74%)
Myriad Genetics: The Streak of Missing Estimates Puts Management Credibility on the Line

Barchart Research What to Expect from MYGN Earnings MYGN Generated July 29, 2026 Current Price $5.05 EPS Estimate $$-0.08 Consensus Rating Hold Average Move 18.01% Myriad Genetics: The Streak of Missing...

MYGN : 2.86 (-46.74%)
Myriad Genetics (MYGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

Myriad Genetics (MYGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

MYGN : 2.86 (-46.74%)
3 Unprofitable Stocks That Fall Short

3 Unprofitable Stocks That Fall Short

MYGN : 2.86 (-46.74%)
BAX : 26.16 (-2.21%)
PRPL : 8.10 (+11.42%)
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings...

MYGN : 2.86 (-46.74%)
3 Reasons MYGN is Risky and 1 Stock to Buy Instead

3 Reasons MYGN is Risky and 1 Stock to Buy Instead

MYGN : 2.86 (-46.74%)
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

SALT LAKE CITY, July 21, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces the full commercial launch of...

MYGN : 2.86 (-46.74%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 3.59
2nd Resistance Point 3.43
1st Resistance Point 3.14
Last Price 2.86
1st Support Level 2.69
2nd Support Level 2.53
3rd Support Level 2.24

See More

52-Week High 8.59
Fibonacci 61.8% 6.38
Fibonacci 50% 5.70
Fibonacci 38.2% 5.02
Last Price 2.86
52-Week Low 2.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.